Myomo, a wearable medical robotics firm offering improved arm and hand function for those with upper-limb paralysis and neuromuscular condition, has launched MyoPro 2x, the latest in its flagship MyoPro product line.

MyoPro is the only commercial device in the U.S. that, by sensing a patient’s EMG signals through non-invasive sensors, can enable individuals to perform daily activities such as eating, lifting objects, and more.

MyoPro 2x introduces a reimagined approach to donning, providing a more intuitive, efficient, and consistent process to independently put on a device. Fit and function were also improved, which the company believes will lead to better outcomes.

Common customizations were integrated into its standard design to decrease time for clinicians to fit MyoPro 2x to patients. There are also updated training documentation and instruction guides to treat practitioners and users.

Myomo recently rolled out their full certification process for Orthotic & Prosthetic providers to become MyoPro Centers of Excellence to focus on the MyoPro 2x. This process empowers practices to build their own patient pipelines and, once fully certified, to treat patients with the technology and dispense the MyoPro 2x independently.

“Our goals for these enhancements were primarily clinical,” said Malcolm Bock, Myomo’s V.P. Engineering and Product Strategy The product development process was driven by inputs from users and clinicians, along with Myomo’s own product performance data. This patient and clinician focus was generated from the knowledge gained from over 3000 patients who have received a MyoPro. The MyoPro 2x is our best product yet, and we are excited for the significant patient impact of this launch.”

“The MyoPro 2x is about more than innovation—it’s about putting independence back into the hands of users,” added Paul R. Gudonis, chairman and CEO of Myomo. “This launch is the result of our commitment to listen to clinicians and users alike and to deliver meaningful improvements that make a real difference in daily life. The MyoPro 2x furthers our leadership in this new and growing space.”